Correlating surrogate endpoints with overall survival at the individual patient level in BRAF-mutated metastatic melanoma patients treated with vemurafenib Meeting Abstract


Authors: Zabor, E. C.; Heller, G.; Schwartz, L. H.; Chapman, P. B.
Abstract Title: Correlating surrogate endpoints with overall survival at the individual patient level in BRAF-mutated metastatic melanoma patients treated with vemurafenib
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904044
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.e20020
Notes: Meeting Abstract: e20020 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Emily Craig Zabor
    172 Zabor
  3. Paul Chapman
    326 Chapman